If you liked this article you might like

Why Bristol-Myers Squibb May Be a Merger Target Soon
Amazon, Merck, Freshpet: Jim Cramer's Views
Allergan, Schlumberger, IBM: Doug Kass' Views
Merck Is a 'Risk Worth Taking' in Spite of Trump Comments, Top Trader Claims